A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude

NCT01794078 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Acute Mountain Sickness and Fatigue

Interventions

DRUG: Aminophylline 400 mg
DRUG: Ambrisentan 5 mg
OTHER: Placebo

Sponsor

Robert J Noveck, M.D.

Collaborators

[object Object]